NCT06974994 - Resilience to Antibiotic-induced Obesogenic Microbiota: Discovering Mechanism of Microbiota Modulation | Biotech Hunter

Enrollment

125

Participants

Timeline

Start Date

May 8, 2024

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions

Healthy Newborn Infants

Interventions

DIETARY_SUPPLEMENT

Synbiotic Supplement

Bifidobacterium bifidum and human milk oligosaccharides (HMOs)

OTHER

Placebo

Maltodextrin

Trial Locations (1)

RECRUITING

Department of Paediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku